Real-time enrollment status for this graves' disease clinical trial
Current Status
Recruiting
Checked: July 17, 2026 at 6:24 PM UTC
| NCT Number | NCT06727604 |
| Recruiting Status | Recruiting |
| Condition | Graves' Disease |
| Phase | PHASE2 |
| Target Enrollment | 240 participants |
| Active Locations | 64 sites in the US |
| Sponsor | Immunovant Sciences GmbH |
| Last Updated on CT.gov | July 10, 2026 (1 week ago) |
As of July 17, 2026: Clinical trial NCT06727604 is currently recruiting participants. This phase2 study for graves' disease is actively seeking new participants at 64 locations across the United States. The study is sponsored by Immunovant Sciences GmbH. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06727604 is actively recruiting participants as of July 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 64 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06727604 was last updated 1 week ago (July 10, 2026). HelloStudys verifies this status automatically.